ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 756170 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 756170; 2) Community: the network communities that were significantly associated with the response to NSC 756170; 3) Molecule: the relationships between components within communities and NSC 756170; 4) MDR: the compounds that were significantly associated with the NSC 756170.

NSC Compound Enrichment Correlation
NSC 727212 11-[2'-N-Aminopropyl)-aminoethylidene]-5,6-dihydro-5-oxo-2,3 -dimethoxy-6-methyl-8,9-methylenedioxy-11H-indeno[1,2-c]isoq uinoline 0.0181211508101519 0.060686933
NSC 728220 1-(3-Bromo-phenyl)-3-(pyridin-2-ylsulfanyl)-propenone 0.0181211508101519 0.0093111556
NSC 734562 6-(3-Aminopropyl)-9-bromo-5,6-dihydro-3-nitro-5,11-dioxo-11H -indeno[1,2-c]isoquinoline Hydrochloride 0.0181211508101519 0.23825072
NSC 735318 Null 0.0181211508101519 0.25656143
NSC 740504 5,6-Dihydro-6-[3-(2-hydroxyethyl)amino-1-propyl]-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.0181211508101519 0.19396097
NSC 94600 Camptothecin 0.0181211508101519 0.17941105
NSC 99733 Rheumygin 0.0181211508101519 -0.08653564
NSC 621888 Cyclopentanone, 2-[(dimethylamino)methyl]-, hydrochloride (9CI) 0.0185619722391416 0.15858767
NSC 62485 Null 0.0199123109106642 0.14464789
NSC 698955 Null 0.0199123109106642 0.026695868
Total:100  Current:50    [First] [Prev] [Next] [Last]